BiomX Inc.
BiomX Inc. (PHGE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PHGE · as of Jun 9, 2026
Key Statistics
Explore BiomX Inc. Data
phge stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The PHGE analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $38.00, representing +4917.83% upside from the current price of $0.76.
Competitors & Peers
phge competitorsPHGE
ADAP
BRTX
DWTX
EDSA
ERNAStock Performance
Full HistoryAbout BiomX Inc.
BiomX Inc. Operating as a holding company, BiomX Inc. is dedicated to advancing technologies within the realms of defense, security, and essential infrastructure. Its diverse array of offerings features speciali…
what is biomx inc. · phge stock overview · biomx inc. company profile · who is biomx inc. ceo · phge AMEX · biomx inc. headquarters · biomx inc. business segments
About Stock Overview & Key Data
BiomX Inc. (PHGE) is a Healthcare company in the Biotechnology industry, listed on AMEX since Mar 13, 2019. As of the latest trading session, PHGE stock price is $0.76, with a market capitalization of $1.2M. The stock has returned -91.34% over the past 12 months and -59.50% year-to-date.
According to 5 Wall Street analysts, the consensus rating for BiomX Inc. stock is Buy, with an average 12-month price target of $38.00. In fiscal year 2025, BiomX Inc. reported revenue of — and net income of -$36.2M. For detailed data — including BiomX Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BiomX Inc. (PHGE) stock price is $0.76. The stock is traded on AMEX under the ticker symbol PHGE. The 52-week range is $0.36 – $14.71.